ZZZhuo Zhang

Zhuo Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhuo Zhang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Alvaro Andres Ordoñez

    Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, USA

    1 shared publication
  • Fereidoon Daryaee

    Institute for Chemical Biology & Drug Discovery, Department of Chemistry and Department of Radiology, Stony Brook University, Stony Brook, New York, United States of America

    1 shared publication
  • Hui Wang

    Institute for Chemical Biology & Drug Discovery, Department of Chemistry and Department of Radiology, Stony Brook University, Stony Brook, New York, United States of America

    1 shared publication
  • Kayla R. Gogarty

    Institute for Chemical Biology & Drug Discovery, Department of Chemistry and Department of Radiology, Stony Brook University, Stony Brook, New York, United States of America

    1 shared publication
  • Lauren E. Bambarger

    Center for Infection and Inflammation Imaging Research, Center for Tuberculosis Research and Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

    1 shared publication
  • Peter J. Tonge

    Stony Brook University

    1 shared publication

Latest Publications

  • Open Access

    The biodistribution of 5-[18F]fluoropyrazinamide in Mycobacterium tuberculosis-infected mice determined by positron emission tomography

    by Zhuo Zhang, Alvaro A. Ordonez, Peter Smith-Jones, Hui Wang, Kayla R. Gogarty, Fereidoon Daryaee, Lauren E. Bambarger, Yong S. Chang, Sanjay K. Jain, Peter J. Tonge

    5-[18F]F-pyrazinamide (5-[18F]F-PZA), a radiotracer analog of the first-line tuberculosis drug pyrazinamide (PZA), was employed to determine the biodistribution of PZA using PET imaging and ex vivo analysis. 5-[18F]F-PZA was synthesized in 60 min using a halide exchange reaction. The overall decay-corrected yield of the reaction was 25% and average specific activity was 2.6 × 106 kBq (70 mCi)/μmol. The biodistribution of 5-[18F]F-PZA was examined in a pulmonary Mycobacterium tuberculosis mouse model, where rapid distribution of the tracer to the lung, heart, liver, kidney, muscle, and brain was observed. The concentration of 5-[18F]F-PZA was not significantly different between infected and uninfected lung tissue. Biochemical and microbiological studies revealed substantial differences between 5-F-PZA and PZA. 5-F-PZA was not a substrate for pyrazinamidase, the bacterial enzyme that activates PZA, and the minimum inhibitory concentration for 5-F-PZA against M. tuberculosis was more than 100-fold higher than that for PZA.